VIRTUAL REALITY TRAINING AFTER THORACIC SURGERY
VRTS
Effects of Exercise Training With Virtual Reality After Thoracic Surgery
1 other identifier
interventional
30
1 country
1
Brief Summary
This study aims to investigate the effects of virtual reality-based exercise training after thoracic surgery. Participants undergoing lung resection surgery will be assigned to either a virtual reality exercise training group or a control group receiving standard care. Physical function, pulmonary function, exercise capacity, dyspnea, anxiety, depression, and quality of life will be evaluated before and after the intervention. The findings may help determine whether virtual reality-assisted exercise training improves postoperative recovery in patients undergoing thoracic surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 24, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 27, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 27, 2026
CompletedFirst Submitted
Initial submission to the registry
June 26, 2026
CompletedFirst Posted
Study publicly available on registry
July 14, 2026
CompletedJuly 14, 2026
July 1, 2026
1.3 years
June 26, 2026
July 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
FEV1
Forced expiratory volume in one second (FEV1) measured by spirometry.
From baseline to 2 weeks after hospital discharge
FVC
Forced vital capacity (FVC) measured by spirometry.
From baseline to 2 weeks after hospital discharge.
FEF25-75
Forced expiratory flow between 25% and 75% of forced vital capacity measured by spirometry.
From baseline to 2 weeks after hospital discharge.
Secondary Outcomes (7)
Pain Intensity
Baseline, postoperative day 2, and hospital discharge (up to 7 days after surgery).
Exercise Capacity
Baseline, postoperative day 2, and hospital discharge (up to 7 days after surgery)
Anxiety and Depression
Baseline, postoperative day 2, and hospital discharge (up to 7 days after surgery).
Dyspnea
Baseline, postoperative day 2, and hospital discharge (up to 7 days after surgery)
Oxygen Saturation
Baseline, postoperative day 2, and hospital discharge (up to 7 days after surgery).
- +2 more secondary outcomes
Study Arms (2)
Conventional Pulmonary Rehabilitation Group
ACTIVE COMPARATORParticipants received conventional pulmonary rehabilitation and cycle ergometer training after thoracic surgery.
Virtual Reality Exercise Training Group
EXPERIMENTALParticipants received conventional pulmonary rehabilitation, cycle ergometer training, and virtual reality-based exercise training after thoracic surgery.
Interventions
Participants received virtual reality-based exercise training in addition to conventional pulmonary rehabilitation and cycle ergometer training after thoracic surgery.
Participants received conventional pulmonary rehabilitation and cycle ergometer training after thoracic surgery.
Participants underwent thoracic surgery (lobectomy, segmentectomy, pneumonectomy, or wedge resection) according to the clinical indication before receiving the assigned rehabilitation intervention.
Eligibility Criteria
You may qualify if:
- Age between 25 and 70 years Stable symptoms and no other disease affecting pulmonary function (e.g., scoliosis or ankylosing spondylitis) Good cooperation and ability to walk independently Patients who underwent thoracic surgery FEV1 \> 2 L for pneumonectomy, \> 1 L for lobectomy, and \> 0.6 L for segmentectomy Maximum oxygen consumption (VO₂max) \> 15-20 mL/kg/min Cycle ergometer performance \> 83 W No severe visual impairment Approved for participation in exercise training by the operating physician Hodkinson Mental Test score \> 6 Willingness to participate and provision of informed consent -
You may not qualify if:
- Contraindications to pulmonary rehabilitation or physiotherapy, including unstable cardiovascular disease, severe pulmonary hypertension, severe uncorrectable hypoxemia, exercise-induced desaturation, rib fractures, subcutaneous emphysema, advanced osteoporosis, or thrombocytopenia Orthopedic or neurological disorders that may impair independent ambulation, exertional dyspnea, or exertional vertigo Requirement for repeat thoracic surgery due to previous thoracic surgical history Inability to establish verbal and/or auditory communication and cooperation Inability to cooperate due to psychological and/or perceptual impairments Withdrawal Criteria Development of unexpected chest pain during the study Occurrence of syncope or nausea during testing procedures Participants may withdraw from the study at any time without providing a reason Study Completion / Termination Criterion Achievement of the planned sample size
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pamukkale University Hospital
Denizli, 20160, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Orçin T ATALAY, PhD
Pamukkale University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof.Dr. Head of Cardiopulmonary Rehabilitation Unıt
Study Record Dates
First Submitted
June 26, 2026
First Posted
July 14, 2026
Study Start
October 24, 2024
Primary Completion
February 27, 2026
Study Completion
February 27, 2026
Last Updated
July 14, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared because the study was conducted as part of an academic thesis project and the informed consent process did not include provisions for public sharing of de-identified participant-level data.